title: Hypertrophic Osteoarthropathy Secondary to Lung Cancer: Beneficial Effect of Anti-vascular Endothelial Growth Factor Antibody.
authors.affiliation: Department of Respiratory Medicine Tokyo Medical University Ibaraki Medical Center 3-20-1 Chuou, Ami, Inashiki Ibaraki 300-0395, Japan kaoshiba@tokyo-med.ac.jp.
authors.forename: Ryota
authors.initials: R
authors.lastname: Kikuchi
authors.forename: Masayuki
authors.initials: M
authors.lastname: Itoh
authors.forename: Makoto
authors.initials: M
authors.lastname: Tamamushi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Nakamura
authors.forename: Kazutetsu
authors.initials: K
authors.lastname: Aoshiba
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000378:metabolism / Q000473:pathology; D000077192:Adenocarcinoma of Lung; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D000068258:Bevacizumab / Q000008:administration & dosage*; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D051546:Cyclooxygenase 2 / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010005:Osteoarthropathy, Secondary Hypertrophic / Q000175:diagnosis / Q000209:etiology; D011859:Radiography / Q000379:methods*; D011877:Radionuclide Imaging / Q000379:methods*; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods*; D013479:Superior Vena Cava Syndrome / Q000175:diagnosis / Q000209:etiology; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human